These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 15870576

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The psychosocial impact of macular degeneration.
    Williams RA, Brody BL, Thomas RG, Kaplan RM, Brown SI.
    Arch Ophthalmol; 1998 Apr; 116(4):514-20. PubMed ID: 9565052
    [Abstract] [Full Text] [Related]

  • 8. Vision-related quality of life in patients with bilateral severe age-related macular degeneration.
    Cahill MT, Banks AD, Stinnett SS, Toth CA.
    Ophthalmology; 2005 Jan; 112(1):152-8. PubMed ID: 15629836
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Quality of life in patients with age-related macular degeneration.
    Šiaudvytytė L, Mitkutė D, Balčiūnienė J.
    Medicina (Kaunas); 2012 Jan; 48(2):109-11. PubMed ID: 22491386
    [Abstract] [Full Text] [Related]

  • 12. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons.
    Mangione CM, Berry S, Spritzer K, Janz NK, Klein R, Owsley C, Lee PP.
    Arch Ophthalmol; 1998 Feb; 116(2):227-33. PubMed ID: 9488276
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Baseline characteristics, the 25-Item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT).
    Maguire M, Complications of Age-Related Macular Degeneration Prevention Trial Research Group.
    Ophthalmology; 2004 Jul; 111(7):1307-16. PubMed ID: 15234130
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Visual function in patients with choroidal neovascularization resulting from age-related macular degeneration: the importance of looking beyond visual acuity.
    Fletcher DC, Schuchard RA.
    Optom Vis Sci; 2006 Mar; 83(3):178-89. PubMed ID: 16534460
    [Abstract] [Full Text] [Related]

  • 17. Quality of life in patients with age-related macular degeneration: impact of the condition and benefits of treatment.
    Slakter JS, Stur M.
    Surv Ophthalmol; 2005 Mar; 50(3):263-73. PubMed ID: 15850815
    [Abstract] [Full Text] [Related]

  • 18. Improvements in measures of vision and self-reported visual function after cataract extraction in patients with late-stage age-related maculopathy.
    Mallah MK, Hart PM, McClure M, Stevenson MR, Silvestri G, White ST, Chakravarthy U.
    Optom Vis Sci; 2001 Sep; 78(9):683-8. PubMed ID: 11587203
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Determinants of health related quality of life and health state utility in patients with age related macular degeneration: the association of contrast sensitivity and visual acuity.
    Bansback N, Czoski-Murray C, Carlton J, Lewis G, Hughes L, Espallargues M, Brand C, Brazier J.
    Qual Life Res; 2007 Apr; 16(3):533-43. PubMed ID: 17119846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.